Literature DB >> 18632526

Intraductal papillary mucinous neoplasm of the pancreas: assessment of the likelihood of invasiveness with multisection CT.

Hiroshi Ogawa1, Shigeki Itoh, Mitsuru Ikeda, Kojiro Suzuki, Shinji Naganawa.   

Abstract

PURPOSE: To evaluate the capabilities of multisection computed tomography (CT) in determining the likelihood of invasiveness of intraductal papillary mucinous neoplasm (IPMN).
MATERIALS AND METHODS: The institutional review board approved this research and waived informed consent from the patients. Two radiologists blinded to the pathologic assessment of malignancy or parenchymal invasion of IPMN retrospectively evaluated CT images of 61 consecutive surgically resected tumors (26 adenomas, 15 noninvasive carcinomas, and 20 invasive carcinomas) in patients who underwent multiphase contrast material-enhanced CT with 0.5- or 1-mm collimation. The findings were statistically analyzed by using univariate and multivariate analyses, with the optimal cutoff levels of each continuous parameter determined by generating receiver operating characteristic curves.
RESULTS: The following findings showed significant differences among the three groups: maximum diameter of the main pancreatic duct (MPD), size (length of major axis) of the largest mural nodule in the MPD or in any associated cystic lesion, abnormal attenuating area in the surrounding parenchyma, calcification in the lesion, protrusion of the MPD into the ampulla of Vater, and bile duct dilatation. An MPD diameter of 6 mm or larger, a mural nodule of 3 mm or larger, and an abnormal attenuating area were independently predictive of malignancy. A mural nodule of 6.3 mm or larger in the MPD and an abnormal attenuating area were independently predictive of parenchymal invasion. According to these criteria, the sensitivity, specificity, and accuracy for identifying malignancy were 83%, 81%, and 82% and for identifying parenchymal invasion were 90%, 88%, and 89%, respectively.
CONCLUSION: Multisection CT is useful for distinguishing among adenoma, noninvasive carcinoma, and invasive carcinoma in patients with IPMN. RSNA, 2008

Entities:  

Mesh:

Year:  2008        PMID: 18632526     DOI: 10.1148/radiol.2482071578

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  28 in total

1.  Comparison between MRI with MR cholangiopancreatography and endoscopic ultrasonography for differentiating malignant from benign mucinous neoplasms of the pancreas.

Authors:  Jiyoung Hwang; Young Kon Kim; Ji Hye Min; Woo Kyung Jeong; Seong Sook Hong; Hyun-Joo Kim
Journal:  Eur Radiol       Date:  2017-08-04       Impact factor: 5.315

2.  Cystic Neoplasm of the Pancreas.

Authors:  Alessandra Pulvirenti; Giovanni Marchegiani; Giuseppe Malleo; Alex Borin; Valentina Allegrini; Claudio Bassi; Roberto Salvia
Journal:  Indian J Surg       Date:  2015-10-28       Impact factor: 0.656

3.  Intraductal papillary mucinous neoplasm in chronic calcifying pancreatitis: egg or hen?

Authors:  Evangelos Kalaitzakis; Barbara Braden; Palak Trivedi; Yalda Sharifi; Roger Chapman
Journal:  World J Gastroenterol       Date:  2009-03-14       Impact factor: 5.742

4.  Colloid carcinoma of the pancreas.

Authors:  Timothy A Plerhoples; Michael Ahdoot; Michael A DiMaio; Reetesh K Pai; Walter G Park; George A Poultsides
Journal:  Dig Dis Sci       Date:  2011-01-21       Impact factor: 3.199

5.  Does preoperative cross-sectional imaging accurately predict main duct involvement in intraductal papillary mucinous neoplasm?

Authors:  M R Barron; A M Roch; J A Waters; J A Parikh; J M DeWitt; M A Al-Haddad; E P Ceppa; M G House; N J Zyromski; A Nakeeb; H A Pitt; C Max Schmidt
Journal:  J Gastrointest Surg       Date:  2014-01-09       Impact factor: 3.452

6.  Prediction of invasive carcinoma in branch type intraductal papillary mucinous neoplasms of the pancreas.

Authors:  Atsushi Kanno; Kennichi Satoh; Morihisa Hirota; Shin Hamada; Jun Umino; Hiromichi Itoh; Atsushi Masamune; Tohru Asakura; Tooru Shimosegawa
Journal:  J Gastroenterol       Date:  2010-04-10       Impact factor: 7.527

7.  Interobserver agreement for detection of malignant features of intraductal papillary mucinous neoplasms of the pancreas on MDCT.

Authors:  Richard K G Do; Seth S Katz; Marc J Gollub; Jian Li; Jennifer LaFemina; Emily C Zabor; Chaya S Moskowitz; David S Klimstra; Peter J Allen
Journal:  AJR Am J Roentgenol       Date:  2014-11       Impact factor: 3.959

8.  Plectin-1 is a biomarker of malignant pancreatic intraductal papillary mucinous neoplasms.

Authors:  Dirk Bausch; Mari Mino-Kenudson; Carlos Fernández-Del Castillo; Andrew L Warshaw; Kimberly A Kelly; Sarah P Thayer
Journal:  J Gastrointest Surg       Date:  2009-09-17       Impact factor: 3.452

9.  Magnetic resonance pancreatography: comparison of two- and three-dimensional sequences for assessment of intraductal papillary mucinous neoplasm of the pancreas.

Authors:  Jin-Young Choi; Jeong Min Lee; Min Woo Lee; Soo Jin Kim; Sun Young Choi; Ji Yang Kim; Joon Koo Han; Byung Ihn Choi
Journal:  Eur Radiol       Date:  2009-04-18       Impact factor: 5.315

10.  Imaging features of intraductal papillary mucinous neoplasms of the pancreas in multi-detector row computed tomography.

Authors:  Ling Tan; Ya-E Zhao; Deng-Bin Wang; Qing-Bing Wang; Jing Hu; Ke-Min Chen; Xia-Xing Deng
Journal:  World J Gastroenterol       Date:  2009-08-28       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.